While there was no significant difference between the drug and placebo ... the development of its earlier lead candidate – PXT864 (baclofen and acamprosate) for Alzheimer’s disease ...

One thing that makes several of them stand out is that drug use from their recent or distant past is not a major issue, is overshadowed by other issues or is not currently raising a furor in an ...

Nanomedicine. 2010;5(1):99-108. Adult mesenchymal stem cells have promising therapeutic potential in human medicine for CNS cell therapy and are already used for autologous transplantation in ...

Nov. 19, 2024 — A research article shows that Eradivir's patent-pending antiviral therapeutic called EV25 reduces lung viral loads of advanced-stage influenza in ... Promising Daily Tablet ...